evidencegaps
Primary study · included by 1 review

Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease.

Moller-Hansen 2021 · Møller-Hansen Michael, Larsen Ann-Cathrine, Toft Peter Bjerre, et al. · The ocular surface · 2021

Included by

Efficacy and safety of stem cell therapy for dry eye syndrome in Sjögren's syndrome: a systematic review and meta-analysis.
Non-Cochrane · intervention · 2026 · cited as Moller-Hansen 2021 · Table 1; References 16-20

The review does not say which of its outcomes this study informs.

1 including review in total.